Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration

Cancer Research

Volumn 58, Issue 4, 1998, Pages 808-814

  Dinney, Colin P N ^a,b   Bielenberg, Diane R ^a   Perrotte, Paul ^a   Reich, Reuven ^a   Eve, Beryl Y ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; DOWN-REGULATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERFERON-ALPHA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032519590     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Folkman, J. Angiogenesis: initiation and modulation. In: Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects, pp. 201-209. New York: Raven Press, 1984.
2. Folkman, J. The role of angiogenesis in tumor growths. Semin. Cancer Biol., 3: 65-71, 1992.
3. Naito, S., von Eschenbach, A. C., Giavazzi, R., and Fidler, I. J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res., 46: 4109-4115, 1986.
4. Gohji, K., Nakajima, M., Dinney, C. P. N., Fan, D., Pathak S., Killion, J. J., von Eschenbach, A. C., and Fidler, I. J. The importance of orthotopic implantation to the isolation and biological characterization of a metastatic human clear-cell renal carcinoma in nude mice. Int. J. Oncol., 2: 23-32, 1993.
5. Fabra, S., Nakajima, M., Bucana, C. D., and Fidler, I. J. Modulation of the invasive phenotype of human colon carcinoma cells by fibroblasts from orthotopic or ectopic organs of nude mice. Differentiation, 52: 101-110, 1992.
6. Gohji, K., Nakajima, M., Fabra, A., Bucana, C. D., von Eschenbach, A. C., Tsuruo, T., and Fidler, I. J. Regulation of metalloproteinase production in metastatic renal-cell carcinoma by organ-specific fibroblasts. Jpn. J. Cancer Res., 55: 152-160, 1994.
7. Singh, R. K., Bucana, C. D., Gutman, M., Fan, D., Wilson, M. R., and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol., 145: 365-374, 1994.
8. Gutman, M., Sing, R. K., Xie, K., Bucana, C. D., and Fidler, I. J. Regulation of IL-8 expression in human melanoma cells by the organ environment. Cancer Res., 55: 2470-2475, 1995.
9. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferons-α and -β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 4562-4566, 1995.
10. Dianzani, F. Interferon treatments: how to use an endogenous system as a therapeutic agent. J. Interferon Res., 12: 109-118, 1992.
11. Sinkovics, J. G. Kaposi's sarcoma: its oncogenes and growth factors. Clin. Rev. Oncol. Hematol., 11: 87-107, 1991.
12. Kirn, D. H., and Kramer, A. Long-term freedom from disease progression with interferon-α therapy in two patients with malignant hemangiopericytoma. J. Natl. Cancer Inst., 88: 764-765, 1996.
13. Ezekowitz, R. A. B., Mulliken, J. B., and Folkman, J. Interferon-α-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med., 326: 1456-1463, 1992.
14. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
15. Chodak, G. W., Hospelhorn, V., Judge, S. M., Mayforth, R., Kowppen, H., and Sasse, J. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res., 48: 2083-2088, 1988.
16. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-361, 1994.
17. Dinney, C. P. N., Fishbeck, R., Singh, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler. I. J., and Killion, J. J. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 54: 1532-1538, 1995.
18. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S. C., Skinner, D. G., and Nichols, P. W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst., 87: 1603-1612, 1995.
19. Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52: 2745-2756, 1973.
20. Vecchi, A., Garlanda, C., Lampugnani, M. G., Resnati, M., Matteucci, C., Stopacciaro, A., Schnurch, H., Risau, W., Ruco, L., Mantovani, A., and Dejana, E. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol., 63: 247-254, 1994.
21. Fan, D., Chakrabarty, S., Seid, C., Bell, C. W., Schackert, H., Morikawa, K., and Fidler, I. J. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-β1. Cancer Communications, 1: 117-125, 1989.
22. Fort, P., Marty, L., Liechaczyk, M., Sabrouty, S. E., Dani, C., and Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatidehydrogenase multigene family. Nucleic Acids Res., 13: 1431-1442, 1985.
23. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsbrun, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
24. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
25. Bucana, C. D., Radinsky, R., Dong, Z., Sanchez, R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J. Histochem. Cytochem., 41: 499-506, 1993.
26. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
27. Kitadai, K., Bucana, C. D., Ellis, L. M., Anzai, H., Tahara, E., and Fidler, I. J. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol., 147: 1238-1247, 1995.
28. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943, 1993.
29. Brouty-Boye, D., and Zetter, B. R. Inhibition of cell motility by Interferon. Science (Washington DC), 208: 516-518, 1980.
30. Gutterman, J. U. Cytokine therapeutics: lessons from interferon-α. Proc. Natl. Acad. Sci. USA, 91: 1198-1205, 1994.
31. Sidky, Y. A., and Borden, E. C. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res., 47: 5155-5161, 1987.
32. Dvorak, H. F., and Gresser, I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J. Natl. Cancer Inst., 81: 497-502, 1989.
33. Maheshwari, R. K., Srikantan, V., Bhartiya, D., Kleinman, H. K., and Grant, D. S. Differential effects of interferon-γ and -α on in vitro model of angiogenesis. J. Cell. Physiol., 146: 164-169, 1991.
34. Gresser, I. Antitumor effects of interferon. Acta Oncol. 28: 347-353, 1989.
35. Baron, S., Tyring, S. K., Fleischmann, W. R., Jr., Coppenharer, D. H., Niesel, D. W. Klimpel, G. R., Stanter, G. J., and Hughes, T. K. The interferons. Mechanisms of action and clinical applications. J. Am. Med. Assoc., 266: 1375-1383, 1991.
36. Larner, A. C., Jonak, G., Cheng, Y-S. E., Korant, B., Knight, E., and Darnell, J. E., Jr. Transcriptional induction of two genes in human cells by β interferon. Proc. Natl. Acad. Sci. USA, 81: 6733-6737, 1984.
37. 1 arrest. Nature (Lond.), 313: 597-600, 1985.
38. Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., and Stark, G. R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell, 38: 745-755, 1984.
39. Knight, E., Jr., Anton, E. D., Fahey, D., Friedland, B. K., and Jonak, G. J. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl. Acad. Sci. USA, 82: 1151-1154, 1985.
40. Harvey, W. H., Harb, O. S., Kosak, S. T., Sheaffer, J. C., Lowe, L. R., and Heerema, N. A. Interferon-α-2b down-regulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb, and c-fos in eskol, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Leuk. Res., 18: 577-585, 1994.
41. Shibata, F., Baird, A., and Florkiewicz, R. Z. Functional characteristics of the human basic fibroblast growth factor gene promoter. Growth Factors, 4: 277-287, 1991.
42. Balkwill, F. R. Cytokines in Cancer Therapy. London: Oxford University Press, 1989.
43. Lippman, S. M., Parkinson, D. R., Intri, L. M., Itri, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., and Hong, W. K. 13-cis Retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of skin. J. Natl. Cancer Inst., 84: 235-241, 1992.
44. Oberg, K. The action of interferon α on human carcinoid tumors. Semin. Cancer Biol., 3: 35-41, 1992.
45. Dvorak, H., and Gresser, I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J. Natl. Cancer Inst., 81: 497-502, 1989.
46. Hathorn, R. W., Tso, C. L., Kaboo, R., Pang, S., Figlin, R., Sawyers, C., deKernion, J. B., and Belldegrun, A. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-α gene transfer. Cancer (phlia.), 74: 1904-1911, 1994.